ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02805660
Brief Title: Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC

First Submitted : June 10, 2016
First Submitted that Met QC Criteria : June 17, 2016
First Posted : June 20, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 4, 2018
Last Update Posted : December 6, 2018